News

CALL FOR PAPERS JANUARY 2026

IJSAR going to launch new issue Volume 07, Issue 01, January 2026; Open Access; Peer Reviewed Journal; Fast Publication. Please feel free to contact us if you have any questions or comments send email to: editor@scienceijsar.com

IMPACT FACTOR: 6.673

Submission last date: 20th January 2026

Non-Carcinogenic Genotoxic Drugs (NCGDS): A new concept of old drugs with Genotoxic side effects

×

Error message

  • Notice: Trying to access array offset on value of type int in element_children() (line 6609 of /home1/sciensrd/public_html/scienceijsar.com/includes/common.inc).
  • Notice: Trying to access array offset on value of type int in element_children() (line 6609 of /home1/sciensrd/public_html/scienceijsar.com/includes/common.inc).
  • Deprecated function: implode(): Passing glue string after array is deprecated. Swap the parameters in drupal_get_feeds() (line 394 of /home1/sciensrd/public_html/scienceijsar.com/includes/common.inc).
Author: 
Gao-De Li
Page No: 
10460-10462

We first proposed that non-carcinogenic genotoxic drugs (NCGDs) can alter gene expression patterns through affecting 3D genome structure, which makes NCGDs be able to prevent viral infections. The NCGDs exclusively refer to old drugs that are non-carcinogenic but have genotoxic side effects that influence 3D genome structure. Some old drugs that induce expression of many genes, but no obvious genotoxicity is tested out, also belong to NCGDS. In a word, any old drugs with genotoxic side effects that are non-carcinogenic but can alter expression of many genes are named as NCGDs. One feature of NCGDs is cure-all properties, leading them to be able to treat many diseases. In this paper, a mini review on history and function of NCGDs is presented.

Download PDF: